NO20004880D0 - Use of inhibitors of retinoic acid activity to reduce hair loss - Google Patents

Use of inhibitors of retinoic acid activity to reduce hair loss

Info

Publication number
NO20004880D0
NO20004880D0 NO20004880A NO20004880A NO20004880D0 NO 20004880 D0 NO20004880 D0 NO 20004880D0 NO 20004880 A NO20004880 A NO 20004880A NO 20004880 A NO20004880 A NO 20004880A NO 20004880 D0 NO20004880 D0 NO 20004880D0
Authority
NO
Norway
Prior art keywords
inhibitors
retinoic acid
hair loss
acid activity
reduce hair
Prior art date
Application number
NO20004880A
Other languages
Norwegian (no)
Other versions
NO20004880L (en
Inventor
Jean-Daniel Doutremepuich
Carole Marconnet
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of NO20004880D0 publication Critical patent/NO20004880D0/en
Publication of NO20004880L publication Critical patent/NO20004880L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20004880A 1998-03-31 2000-09-28 Use of inhibitors of retinoic acid activity to reduce hair loss NO20004880L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803978A FR2776511B1 (en) 1998-03-31 1998-03-31 USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY
PCT/FR1999/000687 WO1999049838A1 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss

Publications (2)

Publication Number Publication Date
NO20004880D0 true NO20004880D0 (en) 2000-09-28
NO20004880L NO20004880L (en) 2000-11-30

Family

ID=9524693

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004880A NO20004880L (en) 1998-03-31 2000-09-28 Use of inhibitors of retinoic acid activity to reduce hair loss

Country Status (16)

Country Link
EP (1) EP1066017A1 (en)
JP (1) JP2002509870A (en)
KR (1) KR20010042104A (en)
CN (1) CN1298290A (en)
AR (1) AR015551A1 (en)
AU (1) AU2938899A (en)
BR (1) BR9908411A (en)
CA (1) CA2324899A1 (en)
FR (1) FR2776511B1 (en)
HU (1) HUP0102411A3 (en)
IL (1) IL137859A0 (en)
NO (1) NO20004880L (en)
PL (1) PL343004A1 (en)
RU (1) RU2193877C2 (en)
WO (1) WO1999049838A1 (en)
ZA (1) ZA200004483B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (en) * 1995-05-03 1997-05-30 Cird Galderma USE OF RETINOIDS IN A COSMETIC COMPOSITION OR FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION
FR2739777B1 (en) * 1995-10-11 1997-11-14 Cird Galderma LIGAND ANTAGONIST RAR-GAMMA OR AGONIST RAR-ALPHA AS AN APOPTOSIS INHIBITOR
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
EP0889032A4 (en) * 1996-03-18 2000-01-05 Eisai Co Ltd Fused-ring carboxylic acid derivatives

Also Published As

Publication number Publication date
AU2938899A (en) 1999-10-18
BR9908411A (en) 2000-12-05
KR20010042104A (en) 2001-05-25
JP2002509870A (en) 2002-04-02
CN1298290A (en) 2001-06-06
AR015551A1 (en) 2001-05-02
PL343004A1 (en) 2001-07-30
HUP0102411A3 (en) 2002-12-28
NO20004880L (en) 2000-11-30
CA2324899A1 (en) 1999-10-07
FR2776511A1 (en) 1999-10-01
WO1999049838A1 (en) 1999-10-07
EP1066017A1 (en) 2001-01-10
HUP0102411A2 (en) 2001-11-28
RU2193877C2 (en) 2002-12-10
IL137859A0 (en) 2001-10-31
ZA200004483B (en) 2002-02-27
FR2776511B1 (en) 2001-05-11

Similar Documents

Publication Publication Date Title
PT1070069E (en) BICYCLICAL DERIVATIVES OF HYDROXAMIC ACID
PT1037880E (en) MIMETIC ANILIDES OF RETINOIC ACID
ID26171A (en) PROCESS FOR DIRECT OXIDATION OF OLEFIN TO OLEFIN OXIDES
ATE371457T1 (en) USE OF ANTIMYCOTICS FOR THE TOPICAL TREATMENT OF FUNGAL-INDUCED MUCOUS INFLAMMATION
ATE273008T1 (en) USE OF NICOTINIC ACID DERIVATIVES TO TREAT DNA DAMAGE TO SKIN CELLS
ATE288748T1 (en) USE OF RETIGABINE TO TREAT NEUROPATHIC PAIN
AU2001290936A1 (en) Application of water nanoclusters to skin
ID28111A (en) METHODS TO IMPROVE SKIN HEALTH
DE69825607D1 (en) REDUCTION OF HAIR GROWTH
DE69511240D1 (en) DERIVATIVES OF HYDROXAMIC ACID AS METALLOPROTEINAS INHIBITORS
NO20004188L (en) Aqueous formulations of parasite removers for application to the skin
IS5333A (en) Prostaglandin derivatives without side effects to treat glaucoma
ZA978400B (en) Use of inhibitors of the activity of retinoic acid to promote healing.
ATE232378T1 (en) CLEANSING PLASTERS TO IMPROVE SKIN CONDITION
PT1007512E (en) BRANCHED ALCOHOL-SUBSTITUTED 2-AMINOPYRIDINES USED AS INHIBITORS OF US
EE03745B1 (en) Substituted 4-Biphenyl-4-hydroxybutanoic Acid Derivatives as Inhibitors of Metalloprotease Matrix
ATE218862T1 (en) USE OF 1-HYDROXY-2-PYRIDONES TO TREAT SKIN INFECTIONS
ID27020A (en) COSMETIC METHOD OF SKIN CARE
ID29792A (en) CONTROLLED REMOVAL FORMULATION TO TREAT CORP
DE60119076D1 (en) Use of pyrometer data to determine oxidation
DE69704197D1 (en) Use of citric acid esters to improve the washability of oil-containing cosmetic compositions
DE59712085D1 (en) Catalytically active combination of active ingredients to enhance the bleaching effect
NO20004880D0 (en) Use of inhibitors of retinoic acid activity to reduce hair loss
HK1045260B (en) Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
NO981866L (en) Therapeutic use of hemoglobin to promote wound healing